Nortech Systems Inc: Form 10-Q for the period ended Jun 30, 2016
Filed with the SEC on Aug 3, 2016 and accepted by EDGAR at Aug 3, 2016, 16:32 ET.
Management's discussion and analysis
As filed, 24,319 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Overview
We are a Maple Grove, Minnesota based full-service electronics manufacturing services (“EMS”) contract manufacturer of wire and cable assemblies, printed circuit board assemblies, higher-level assemblies and box builds for a wide range of industries. We provide value added engineering services and technical support including design, testing, prototyping and supply chain management to customers mainly in the aerospace and defense, medical, and industrial equipment markets. We maintain facilities in Bemidji, Blue Earth, Eden Prairie, Mankato, Merrifield, and Milaca, Minnesota; Augusta, Wisconsin; Monterrey, Mexico; and Suzhou, China. All of our facilities are certified to one or more of the ISO standards, including 9001 and 13485, with most having additional certifications based on the needs of the customers they serve.
Our 2016 second quarter revenue increased by 8% over the prior year, led by our medical customers in both manufacturing and engineering services. Our strategic investment in engineering services helped our growth in the medical market and we believe prospects are good for continued future growth. Our defense revenue continues to stabilize and is showing signs of recovery, while our industrial customers lost some momentum that was building over the past several quarters. Our 90 day backlog as of June 30, 2016, also increased 12% since the start of the quarter.
We are continuing to transform our business model with more early-engagement opportunities and value-added services: engineering design, quick-turn prototyping and additional box-build solutions. Our customers also appreciate our competitive ‘One Nortech’ global manufacturing options.
Operating profits improvements for the second quarter of 2016 over the prior year’s second quarter were aided by the revenue increase and a 170 basis point improvement in gross margin, due to product and service mix. Included in cost of goods sold and negatively impacting the operating profits in the second quarter of 2016 is more than $200,000 in startup costs for our new Asia manufacturing facility.
Increases to working capital in the first six months of 2016 resulted in cash provided by operating activities of $1.1 million.
Summary of Results
Revenue increased in the second quarter of 2016 by $2.1 million or 8%, as compared to the second quarter of the prior year. The medical market increased by $3.6 million or 40%, in the second quarter of 2016 as compared to the same period last year, but was partially offset by decreases in the industrial market. Revenue from the aerospace and defense markets increased by 20% in the second quarter of 2016 as compared to the second quarter of 2015.
Revenue for the medical market sector increased primarily due to increases in demand and engineering services, including $2.0 million related to additional Devicix engineering service in the second quarter of 2016.
The net decrease in the industrial market sector of $2.1 million in the second quarter of 2016 as compared to the same quarter of 2015, resulted primarily from lower demand levels. Our semiconductor and transportation equipment customers were the main reasons for the decrease.
The defense market returned to growth in 2016. The increase is due to increased demand in molded wire and cable product. We have worked diligently with our customers to reflect our value and unique capabililities in custom molded cable assembly technology.
Our second quarter gross profit increased to 10.8% of sales versus 9.1% in the second quarter of the prior year. Our gross profit percentage for the six months ended June 30, 2016 was 11.2% compared to 9.9% for the six months ended June 30, 2015. Impacting gross profit in both the second quarter and the first half of the year were volume, product and service mix and the inclusion of Devicix engineering services.
Selling, general and administrative expenses increased approximately $320,000 to 11.2% of sales in the second quarter of 2016, compared to 10.9% of sales in the same quarter of the prior year. The increase in selling, general and administrative expense was primarily due to the addition of Devicix expenses and the related amortization expense, not reflected in the prior year due to being acquired in the third quarter of 2015.
Second quarter 2016 loss from operations was approximately $110,000 as compared to a loss from operations of approximately $483,000 for the second quarter in 2015. For the first six months of the year ended 2016, income from operations was approximately $111,000 as compared to a loss from operations of $685,000 for the same period last year. An improvement of approximately $373,000 for the quarter and approximately $776,000 for the six months was due to the increased revenue and an improved gross margin product and service mix.
Net loss for the three months ended June 30, 2016 was approximately $180,000 or $0.07 loss per basic and diluted common share, compared to net loss for the three months ended June 30, 2015 of approximately $378,000 or $0.14 loss per basic and diluted common share. Net loss for the first six months of 2016 was approximately $117,000 or $0.04 loss per basic and diluted common share, compared to net loss of approximately $571,000 or $0.21 loss per basic and diluted common share for the same period in 2015.
Cash provided by operating activities for the first six months of 2016 was approximately $1,059,000, as compared to cash flow used by operations in the first six months of 2015 of approximately $137,000. The noncash addback of depreciation and amortization positively impacted cash flows along with increases in accounts payable through the extension of terms and conditions, offset by increases in inventory.
Results of Operations
The following table presents statements of operations data as percentages of total net sales for the periods indicated:
| Three Months Ended June 30 2016 | 2015 | Six Months Ended June 30 2016 | 2015 | |
|---|---|---|---|---|
| Net Sales | 100.0% | 100.0% | 100.0% | 100.0% |
| Cost of Goods Sold | 89.2 | 90.9 | 88.8 | 90.1 |
| Gross Profit | 10.8 | 9.1 | 11.2 | 9.9 |
| Selling Expenses | 4.5 | 4.9 | 4.5 | 5.0 |
| General and Administrative Expenses | 6.7 | 6.0 | 6.5 | 6.2 |
| Income (Loss) from Operations | (0.4) | (1.8) | 0.2 | (1.3) |
| Other Expenses, Net | (0.4) | (0.4) | (0.5) | (0.4) |
| Loss Before Income Taxes | (0.8) | (2.2) | (0.3) | (1.7) |
| Income Tax Benefit | (0.2) | (0.8) | (0.1) | (0.6) |
| Net Loss | (0.6)% | (1.4)% | (0.2)% | (1.1)% |
Net Sales
We reported net sales of approximately $28.9 and $26.8 million for the three months ended June 30, 2016 and 2015, respectively. We reported net sales of $57.9 and $53.3 million for the six months ended June 30, 2016 and 2015, respectively.
For the second quarter of 2016, our medical and defense customers led the increase in revenue, up 40% and 20%, respectively, over the prior year’s second quarter, and was up 33% and 25%, respectively, for the six months ended June 30, 2016, as compared to the six months ended June 30, 2015. Our Devicix acquisition accounted for $2.0 million and $3.6 million of increase in medical revenue for the three and six month periods ended June 30, 2016, respectively. These increases were offset by a decrease in revenue from our industrial customers of 15% for the second quarter of 2016, as compared to the second quarter of 2015, and 11% for the six months ended June 30, 2016, as compared to the six months ended June 30, 2015. Our industrial customers in the transportation and semi-conductor market sectors are being impacted by a sluggish overall economy in the first half of 2016.
Net sales by our major EMS industry markets for the three and six month periods ended June 30, 2016 and 2015 were as follows:
| Three Months Ended June 30 | Six Months Ended June 30 | |
|---|---|---|
| 2016 2015% | 2016 2015% | |
| (in thousands) | $$ Change | $$ Change |
| Aerospace and Defense | 4,376 3,639 20 | 8,396 6,691 25 |
| Medical | 12,613 9,027 40 | 24,209 18,192 33 |
| Industrial | 11,956 14,135 (15) | 25,290 28,458 (11) |
| Total Sales | 28,945 26,801 8 | 57,895 53,341 9 |
Backlog
Our 90-day order backlog as of June 30, 2016 was $22.7 million, an increase of 17% over the prior year and 12% from the beginning of the quarter. Backlog for our medical customers has increased 86% over prior year and 28% over the prior quarter. The Devicix medical device engineering backlog was approximately $0.9 million as of June 30, 2016, and approximately the same amount at the start of the quarter. There was no backlog related to Devicix in the prior year numbers due to the acquisition taking place in the third quarter of 2015.
The aerospace and defense backlog is down slightly from the beginning of the quarter and our industrial customers backlog increased slightly from prior quarter, however, remains much lower than prior year as we continue to see softness in the transportation, semi conductor equipment and oil and gas industries and costs impacting these customers. Our backlog consists of firm purchase orders and we expect a major portion of the current 90 day backlog to be realized as revenue during the following quarter.
90 day backlog by our major EMS industry markets are as follows:
(in thousands)
| Backlog as of the Quarter Ended June 30 2016 | March 31 2016 | June 30 2015 | |
|---|---|---|---|
| Aerospace and Defense | $4,791 | $5,334 | $4,307 |
| Medical | 11,428 | 8,922 | 6,143 |
| Industrial | 6,526 | 5,980 | 8,990 |
| Total Backlog | $22,745 | $20,236 | $19,440 |
Our 90 day backlog varies due to order size, manufacturing delays, contract terms and conditions and timing from customer delivery schedules and releases. These variables cause inconsistencies in comparing the backlog from one period to the next.
Gross Profit
Gross profit as a percent of net sales for the three months ended June 30, 2016 and 2015 was 10.8% and 9.1%, respectively. Gross profit as a percentage of net sales for the six months ended June 30, 2016 and 2015 was
11.2% and 9.9%, respectively. Impacting gross profit in the second quarter and the first half of the year were volume, product and service mix and the inclusion of Devicix engineering services.
Selling Expense
Selling expense for the three months ended June 30, 2016 and 2015 was approximately $1.3 million or 4.5% of sales and approximately $1.3 million or 4.9% of sales, respectively. Selling expense for the six months ended June 30, 2016 and 2015 was $2.6 million or 4.5% of sales and $2.7 million or 5.0% of sales, respectively. The decrease is due to the timing of expenses. We expect to continue funding at an increased rate for business development activities and marketing initiatives to maintain and stimulate sales growth.
General and Administrative Expense
General and administrative expenses for the three months ended June 30, 2016 and 2015 were approximately $1.9 million or 6.7% of sales and approximately $1.6 million or 6.0% of sales, respectively. General and administrative expenses for the six months ended June 30, 2016 and 2015 were $3.8 million or 6.5% of sales and $3.3 million or 6.2% of sales, respectively. The increase in administrative expense was primarily due to the addition of Devicix expenses and the related amortization expense, not reflected in the first half of 2016 as it was acquired in the third quarter of 2015.
Income Taxes
On a quarterly basis, we estimate what our effective tax rate will be for the full fiscal year and record a quarterly income tax provision based on the anticipated rate. As the year progresses, we refine our estimate based on the facts and circumstances, including discrete events, by each tax jurisdiction. Our effective tax rate for the three and six months ended June 30, 2016 was 28% and 27%, respectively. Our effective tax rate for the three and six months ended June 30, 2015 was 36%. The effective tax rate for the year ended December 31, 2016 is expected to be 33% compared to 36% for the year ended December 31, 2015. The decrease is due mainly to the impact of the federal research and development credit.
The differences between federal income taxes computed at the federal statutory rate and reported income taxes for the three months ended June 30, 2016 and 2015 are as follows:
| Three Months Ended June 30 2016 | 2015 | Six Months Ended June 30 2016 | 2015 | |
|---|---|---|---|---|
| Statutory federal tax benefit | $(89,000) | $(188,000) | $(55,000) | $(270,000) |
| State income taxes (benefits) | 13,000 | (16,000) | 16,000 | (26,000) |
| Income tax credits | (17,000) | (12,000) | (40,000) | (25,000) |
| Other | 24,000 | (1,000) | 36,000 | — |
| Income tax benefit | $(69,000) | $(217,000) | $(43,000) | $(321,000) |
Liquidity and Capital Resources
We have satisfied our liquidity needs over the past several years with cash flows generated from operations and an operating line of credit through WFB. We also have real estate and equipment term loans. We have a credit agreement with WFB which was most recently amended on February 22, 2016 and provides for a line of credit arrangement of $15.0 million that expires, if not renewed, on May 31, 2018. The credit arrangement also has a $1.8 million real estate term note outstanding with a maturity date of March 31, 2027, an additional $1.7 million real estate term note outstanding that is due, if not renewed, on December 31, 2027, an equipment loan for $2.7 million and a term loan facility of up to $1.0 million for capital expenditures, both with maturity dates of May 31, 2018.
Both the line of credit and real estate term notes are subject to fluctuations in the LIBOR rates. The line of credit, real estate term notes, and equipment loans with WFB contain certain covenants which, among other things, require us to adhere to regular reporting requirements, abide by annual shareholder dividend limitations, maintain certain financial performance, and limit the amount of annual capital expenditures. The availability under our line is subject to borrowing base requirements, and advances are at the discretion of the lender. The line of credit is secured by substantially all of our assets.
On June 30, 2016, we had outstanding advances of $8.5 million under the line of credit and unused availability of $6.1 million supported by our borrowing base. We believe our financing arrangements and cash flows to be provided by operations will be sufficient to satisfy our future working capital needs. Our working capital was $20.6 and $20.7 million as of June 30, 2016 and December 31, 2015, respectively.
Our credit agreement with WFB requires us to maintain a minimum fixed charge coverage ratio of not less than 1.15 to 1.00. The fixed charge coverage ratio at June 30, 2016 was 1.21 to 1.00. We believe our performance will be sufficient to comply with this covenant going forward.
Net cash provided by operating activities for the six months ended June 30, 2016 was $1.1 million. The noncash addback of depreciation and amortization positively impacted cash flows along with increases in accounts payable through the extension of terms and conditions, offset by increases in inventory.
Net cash used in investing activities of $1.4 million for the six months ended June 30, 2016 is comprised of property and equipment purchases to support the business.
Cash conversion cycle:
| Six Months Ended June 30, 2016 | June 30, 2015 | |
|---|---|---|
| Days in trade accounts receivable | 52 | 53 |
| Days in inventory | 78 | 78 |
| Days in accounts payable | (47) | (35) |
| Cash conversion cycle | 83 | 96 |
We calculate days in accounts receivable as accounts receivable for the respective quarter divided by annualized sales for the respective quarter by day. We calculate days in inventory and accounts payable as each balance sheet line item for the respective quarter divided by annualized cost of sales for the respective quarter by day. We calculate cash conversion cycle as the sum of days in receivable and inventory less days in accounts payable. Items which may cause the cash conversion cycle in a particular period to differ include, but are not limited to, changes in business mix, changes in payment terms and the timing of revenue recoginition and inventory purchases within the period. The decrease in our cash conversion cycle is the result of increased accounts payable. Days in accounts payable for the six months ended June 30, 2016 increased twelve days compared to the six months ended June 30, 2015 as a result of extending vendor terms and conditions.
We do not believe that inflation has had a material impact on our business and operating results during the periods presented.
Off-Balance Sheet Arrangements
We have not engaged in any off-balance sheet activities as defined in Item 303(a)(4) of Regulation S-K.
Critical Accounting Policies and Estimates
Our significant accounting policies and estimates are summarized in Management’s Discussion and Analysis of Financial Condition and Results of Operations in our Annual Report on Form 10-K for the year ended December 31, 2015. There have been no significant changes in these critical accounting policies since December 31, 2015. Some of our accounting policies require us to exercise significant judgment in selecting the appropriate assumptions for calculating financial estimates. Such judgments are subject to an inherent degree of uncertainty. These judgments are based on our historical experience, known trends in our industry, terms of existing contracts and other information from outside sources, as appropriate. Actual results could differ from these estimates.
Recent Accounting Pronouncements
In March 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2016-09, Compensation - Stock Compensation: Improvements to Employee Share-Based Payment Accounting, which changes how companies account for certain aspects of share-based payments to employees. The new guidance requires all income tax effects of awards to be recognized in the income statement when the awards vest or are settled, allows an employer to repurchase more of an employee’s shares than previously allowed for tax withholding purposes without triggering liability accounting, allows a company to make a policy election to account for forfeitures as they occur, and eliminates the requirement that excess tax benefits be realized before companies can recognize them. The new guidance also requires excess tax benefits and tax shortfalls to be presented on the cash flow statement as an operating activity rather than as a financing activity, and clarifies that cash paid to a tax authority when shares are withheld to satisfy its statutory income tax withholding obligation are to be presented as a financing activity. The standard is effective for our financial statements issued for fiscal years beginning after December 15, 2016, and interim periods within those fiscal years. Early adoption is permitted. We are currently evaluating the impact of adoption of this ASU on our consolidated financial statements.
During February 2016, the FASB issued ASU No. 2016-02, “Leases.” ASU No. 2016-02 was issued to increase transparency and comparability among organizations by recognizing all lease transactions (with terms in excess of 12 months) on the balance sheet as a lease liability and a right-of-use asset (as defined). ASU No. 2016-02 is effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years, with earlier application permitted. Upon adoption, the lessee will apply the new standard retrospectively to all periods presented or retrospectively using a cumulative effect adjustment in the year of adoption. We are currently assessing the effect that ASU No. 2016-02 will have on its results of operations, financial position and cash flows.
In November 2015, the FASB issued ASU 2015-17, “Income Taxes (Topic 740) Balance Sheet Classification of Deferred Taxes” which requires that deferred tax assets and liabilities be classified as noncurrent in a classified balance sheet. The amendment takes effect for public entities for fiscal years beginning after December 15, 2016, with early adoption available. We have adopted the standard in this report and reclassified comparative periods for consistency.
In May 2014, the FASB issued ASU 2014-09, “Revenue from Contracts with Customers (Topic 606)”. This standard outlines a single comprehensive model for companies to use in accounting for revenue arising from contracts with customers and supersedes most current revenue recognition guidance, including industry-specific guidance. The core principle of the revenue model is that revenue is recognized when a customer obtains control of a good or service. A customer obtains control when it has the ability to direct the use of and obtain the benefits from the good or service. Transfer of control is not the same as transfer of risks and rewards, as it is considered in current guidance. We will also need to apply new guidance to determine whether revenue should be recognized over time or at a point in time. This standard will be effective for the first interim period within annual reporting periods beginning after December 15, 2017, with no early adoption permitted, using either of two methods: (a) retrospective to each prior reporting period presented with the option to elect certain practical expedients as defined within ASU 2014-09; or (b) retrospective with the cumulative effect of initially applying ASU 2014-09 recognized at the date of initial application and providing certain additional disclosures as defined in ASU 2014-09. We have not yet selected a transition method and are currently evaluating the impact of the pending adoption of ASU 2014-09 on the consolidated financial statements.
Forward-Looking Statements
Those statements in the foregoing report that are not historical facts are forward-looking statements made pursuant to the safe-harbor provisions of the Private Securities Litigation Reform Act of 1995. Such statements generally will be accompanied by words such as “anticipate,” “believe,” “estimate,” “expect,” “forecast,” “intend,” “possible,” “potential,” “predict,” “project,” or other similar words that convey the uncertainty of future events or outcomes. Although we believe these forward-looking statements are reasonable, they are based upon a number of assumptions concerning future conditions, any or all of which may ultimately prove to be inaccurate. Forward-looking statements involve a number of risks and uncertainties. Important factors that could cause actual results to differ materially from the forward-looking statements include, without limitation:
- Volatility in the marketplace which may affect market supply and demand for our products;
- Increased competition;
- Changes in the reliability and efficiency of operating facilities or those of third parties;
- Risks related to availability of labor;
- Increase in certain raw material costs such as copper;
- Commodity and energy cost instability;
- General economic, financial and business conditions that could affect our financial condition and results of operations; and
- Availability of raw material components.
The factors identified above are believed to be important factors (but not necessarily all of the important factors) that could cause actual results to differ materially from those expressed in any forward-looking statement made by us. Unpredictable or unknown factors not discussed herein could also have material adverse effects on forward-looking statements. All forward-looking statements included in this Form 10-Q are expressly qualified in their entirety by the forgoing cautionary statements. We undertake no obligations to update publicly any forward-looking statement (or its associated cautionary language) whether as a result of new information or future events.
Please refer to forward-looking statements and risks as previously disclosed in our Annual Report on Form 10-K for the fiscal year ended December 31, 2015.
Controls and procedures
As filed, 1,458 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Evaluation of Disclosure Controls and Procedures
In accordance with Rule 13a-15(b) of the Securities Exchange Act of 1934 (the “Exchange Act”), as of the end of the period covered by this Quarterly Report on Form 10-Q, our management evaluated, with the participation of our Chief Executive Officer and Chief Financial Officer, the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule 13a-15(e) and Rule 15d-15(e) under the Exchange Act). These controls and procedures are designed to ensure that information required to be disclosed in the Company’s Exchange Act reports is (1) recorded, processed, summarized and reported in a timely manner, and (2) accumulated and communicated to management, including the Company’s Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. Based upon their evaluation of these disclosure controls and procedures as of the date of the evaluation, the Chief Executive Officer and Chief Financial Officer concluded that the disclosure controls and procedures were effective.
Changes in Internal Control Over Financial Reporting
There was no change in our internal control over financial reporting that occurred during the period covered by this Quarterly Report on Form 10-Q that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2016-06-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2016-04-01 to 2016-06-30 | $28.9m | us-gaap:SalesRevenueNet |
| Revenue | 6 months2016-01-01 to 2016-06-30 | $57.9m | us-gaap:SalesRevenueNet |
| Cost of revenue | 3 months2016-04-01 to 2016-06-30 | $25.8m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 6 months2016-01-01 to 2016-06-30 | $51.4m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2016-04-01 to 2016-06-30 | $3.1m | us-gaap:GrossProfit |
| Gross profit | 6 months2016-01-01 to 2016-06-30 | $6.5m | us-gaap:GrossProfit |
| Operating income | 3 months2016-04-01 to 2016-06-30 | −$109.9k | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2016-01-01 to 2016-06-30 | $111.0k | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2016-04-01 to 2016-06-30 | $139.2k | us-gaap:InterestExpense |
| Interest expense | 6 months2016-01-01 to 2016-06-30 | $271.3k | us-gaap:InterestExpense |
| Income tax | 3 months2016-04-01 to 2016-06-30 | −$69.0k | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2016-01-01 to 2016-06-30 | −$43.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2016-04-01 to 2016-06-30 | −$180.2k | us-gaap:NetIncomeLoss |
| Net income | 6 months2016-01-01 to 2016-06-30 | −$117.3k | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2016-04-01 to 2016-06-30 | −$0.07 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2016-01-01 to 2016-06-30 | −$0.04 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2016-04-01 to 2016-06-30 | −$0.07 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2016-01-01 to 2016-06-30 | −$0.04 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2016-04-01 to 2016-06-30 | 2,747,700 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2016-01-01 to 2016-06-30 | 2,747,012 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Capital expenditure | 6 months2016-01-01 to 2016-06-30 | $1.4m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2016-06-30 | $13.5k | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2016-06-30 | $41.3m | us-gaap:AssetsCurrent |
| Total assets | At period end2016-06-30 | $57.7m | us-gaap:Assets |
| Current liabilities | At period end2016-06-30 | $20.7m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2016-06-30 | $35.5m | us-gaap:Liabilities |
| Long-term debt | At period end2016-06-30 | $5.5m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2016-06-30 | $1.5m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2016-06-30 | $22.1m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001104659-16-136573. Last ingested by Listed: Nov 12, 2026, 19:20 ET. Listed shows no prices and gives no investment advice.